| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8728534 | Gastrointestinal Endoscopy | 2017 | 41 Pages |
Abstract
In small-bowel CD patients in clinical remission, many had ongoing mucosal inflammation assessed by CE and fecal biomarkers. Only some developed a clinical flare during medium-term follow-up. These findings suggest CE and fecal biomarkers are useful in monitoring small-bowel CD progress.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Vipul MD, Andrew S. MD, Susan PhD, Steven T. PhD, Gregor PhD, Rajvinder FRACP, MPhil, Antony MD, Amany PhD, Philip I. MD, PhD,